CARS1
Introduction
flowchart TD
CARS1["CARS1"] -->|"associated with"| TLR2["TLR2"]
CARS1["CARS1"] -->|"activates"| TLR2["TLR2"]
CARS1["CARS1"] -->|"associated with"| ALS["ALS"]
CARS1["CARS1"] -->|"associated with"| RNA["RNA"]
CARS1["CARS1"] -->|"associated with"| TLR["TLR"]
CARS1["CARS1"] -->|"co expressed with"| TLR2["TLR2"]
style CARS1 fill:#4fc3f7,stroke:#333,color:#000
CARS1 (Cysteinyl-tRNA Synthetase 1) encodes an essential enzyme responsible for the attachment of the amino acid cysteine to its cognate tRNA molecules. This catalytic activity, termed aminoacylation, is fundamental to protein synthesis and represents one of the most essential enzymatic reactions in all living organisms. Beyond this canonical role in translation, CARS1, like many other aminoacyl-tRNA synthetases, exhibits extra-translational functions including roles in RNA processing, mitochondrial iron-sulfur cluster assembly, and immune regulation. This page provides comprehensive information about CARS1's structure, function, expression patterns, and relevance to neurodegenerative diseases.
...CARS1
Introduction
Mermaid diagram (expand to render)
CARS1 (Cysteinyl-tRNA Synthetase 1) encodes an essential enzyme responsible for the attachment of the amino acid cysteine to its cognate tRNA molecules. This catalytic activity, termed aminoacylation, is fundamental to protein synthesis and represents one of the most essential enzymatic reactions in all living organisms. Beyond this canonical role in translation, CARS1, like many other aminoacyl-tRNA synthetases, exhibits extra-translational functions including roles in RNA processing, mitochondrial iron-sulfur cluster assembly, and immune regulation. This page provides comprehensive information about CARS1's structure, function, expression patterns, and relevance to neurodegenerative diseases.
<div class="infobox infobox-gene">
<div class="infobox-header">Gene Information</div>
<div class="infobox-content">
Symbol: CARS1 (formerly CARS)
Full Name: Cysteinyl-tRNA Synthetase 1
Chromosomal Location: 11p15.5
NCBI Gene ID: [8438](https://www.ncbi.nlm.nih.gov/gene/8438)
OMIM: [601299](https://www.omim.org/entry/601299)
Ensembl ID: [ENSG00000198055](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000198055)
UniProt ID: [P49589](https://www.uniprot.org/uniprotkb/P49589)
Gene Type: Protein coding
Protein Length: 750 amino acids
Associated Diseases: Mitochondrial disorders, Friedreich ataxia, Hepatic failure
</div>
</div>
Gene Family Context
CARS1 belongs to the family of aminoacyl-tRNA synthetases (ARS), which consists of 37 enzymes in humans (one for each amino acid, with some having multiple isoforms):
| ARS | Location | Associated Diseases |
|-----|----------|-------------------|
| CARS1 | Cytosol + Mitochondria | Mitochondrial disease |
| YARS1 | Cytosol | Dominant Charcot-Marie-Tooth |
| GARS1 | Cytosol + Mitochondria | Charcot-Marie-Tooth, CMT2D |
| AARS1 | Cytosol | Charcot-Marie-Tooth, CMT2N |
| HARS1 | Cytosol + Mitochondria | Charcot-Marie-Tooth |
| MARS2 | Mitochondria | Spastic ataxia |
| RARS2 | Mitochondria | Pontocerebellar hypoplasia |
| PARS1 | Mitochondria | Mitochondrial disease |
The CARS1 enzyme is unique among ARS family members in its association with multiple cellular compartments and functions.
Protein Structure and Function
Structural Features
CARS1 has a complex, multi-domain structure:
N-terminal domain: Contains appended domains for non-canonical functions
Core catalytic domain: The conserved Rossmann-fold catalyzes aminoacylation
anticodon-binding domain: Recognizes the tRNA anticodon
C-terminal domain: Additional regulatory and interaction motifsThe protein contains:
- Active site for ATP-dependent cysteine activation
- Zinc finger motif for tRNA binding
- Nuclear localization signals
- Mitochondrial targeting sequence (alternatively spliced)
Catalytic Function
The aminoacylation reaction proceeds through two steps:
Cysteine activation:
Cysteine + ATP → Cys-AMP + PPi
tRNA charging:
Cys-AMP + tRNA^Cys → Cys-tRNA^Cys + AMP
This reaction is essential for decoding the genetic code during translation.
Alternative Splicing
CARS1 undergoes alternative splicing generating multiple isoforms:
- Isoform 1: Full-length (750 aa) with mitochondrial targeting
- Isoform 2: Cytosolic form without mitochondrial targeting
- Isoform 3: Tissue-specific variants
Expression Patterns
Tissue Distribution
CARS1 is expressed ubiquitously with highest levels in:
| Tissue | Expression Level | Functional Implications |
|--------|-----------------|------------------------|
| Heart | Very high | High metabolic demand |
| Skeletal muscle | High | Protein synthesis |
| Brain | High | Neuronal function |
| Liver | High | Metabolic functions |
| Kidney | Moderate | Metabolic functions |
| Lung | Moderate | Metabolic functions |
Brain Expression
Within the brain, CARS1 shows region-specific expression:
- Cerebral cortex: High expression in pyramidal neurons
- Hippocampus: High in CA1-CA3 neurons and dentate gyrus
- Cerebellum: High in Purkinje cells
- Brainstem: Moderate expression
- Spinal cord: Moderate in motor neurons
Subcellular Localization
CARS1 localizes to multiple compartments:
- Cytosol: Primary location for translation
- Mitochondria: Import via targeting sequence
- Nucleus: Present in some cell types
- Stress granules: During stress conditions
This distribution enables both canonical and non-canonical functions.
Role in Cellular Function
Canonical Role: Protein Synthesis
The primary function of CARS1 is ensuring accurate translation:
Cys-tRNA production: Supplies charged tRNA for ribosomal protein synthesis
Quality control: Rejects incorrect amino acids
Reading frame maintenance: Ensures proper decoding
Codon recognition: Recognizes specific tRNA anticodonsThis function is essential for all protein synthesis in the cell.
Non-Canonical Functions
1. Mitochondrial Iron-Sulfur Cluster Assembly
CARS1 participates in iron-sulfur (Fe-S) cluster assembly:
- Interacts with the CIA (Cytosolic Iron-sulfur cluster Assembly) machinery
- Required for transfer of sulfur atoms
- Essential for Fe-S cluster maturation
- Critical for numerous enzyme functions
2. RNA Processing
Some ARS enzymes participate in RNA metabolism:
- Splicing factor recruitment
- RNA modification
- microRNA processing
3. Immune Regulation
CARS1 can be secreted and functions as an immune modulator:
- Extracellular functions as cytokine-like molecule
- Autoantibody target in some autoimmune conditions
- Wound healing and tissue repair
Neurodegenerative Disease Associations
Friedreich Ataxia
CARS1 has a special connection to Friedreich ataxia:
Frataxin Interaction
- Frataxin (FXN) is deficient in Friedreich ataxia
- CARS1 interacts with frataxin in Fe-S cluster assembly
- Impaired function contributes to mitochondrial dysfunction
- May represent therapeutic target
Disease Mechanisms
- Mitochondrial iron accumulation
- Impaired Fe-S cluster enzymes
- Oxidative stress
- Progressive neurodegeneration
Charcot-Marie-Tooth Disease
Mutations in CARS-related genes cause CMT:
- GARS1 (glycyl-tRNA synthetase) mutations cause CMT2D
- CARS1 variants may contribute to peripheral neuropathy
- Mechanisms involve toxic gain-of-function
- Axonal degeneration
Mitochondrial Encephalomyopathies
CARS1 mutations can cause severe disease:
Leigh Syndrome
- Subacute necrotizing encephalomyelopathy
- Severe neurological deterioration
- Bilateral lesions in brainstem
- Early infantile onset
Other Encephalomyopathies
- Combined oxidative phosphorylation deficiencies
- Mitochondrial translation defects
- Seizures and developmental regression
Amyotrophic Lateral Sclerosis (ALS)
Connections to ALS include:
- Mitochondrial dysfunction in motor neurons
- Impaired protein homeostasis
- Stress granule formation
- RNA metabolism alterations
Alzheimer's Disease
Potential roles in AD:
- Mitochondrial dysfunction is a hallmark
- Protein synthesis changes in early AD
- CARS may have protective roles
- Could affect amyloid processing
Therapeutic Implications
Drug Development
CARS1 represents a therapeutic target:
Enzyme activators: Enhance aminoacylation efficiency
Fe-S cluster modulators: Improve mitochondrial function
Protein homeostasis enhancers: Support translation
Gene therapy approaches: Viral deliveryChallenges
Developing CARS1-targeted therapies:
- Essential enzyme function
- Multiple isoforms and locations
- Blood-brain barrier penetration needed
- Potential for compensatory mechanisms
Interactions and Pathway Membership
Protein-Protein Interactions
| Partner | Interaction | Function |
|---------|------------|----------|
| FXN | Frataxin | Fe-S cluster assembly |
| ISCU | Iron-sulfur cluster scaffold | Fe-S assembly |
| NFU1 | Fe-S cluster transfer | Fe-S assembly |
| tRNA^Cys | Substrate | Protein synthesis |
| ABCB7 | Mitochondrial transporter | Fe-S assembly |
| EEF1A1 | Translation factor | Protein synthesis |
Signaling Pathways
CARS1 participates in:
Protein synthesis in cytoplasm (GO:0006412)
Mitochondrial translation (GO:0032543)
Iron-sulfur cluster assembly (GO:0016226)
Immune response (GO:0006955)
tRNA aminoacylation (GO:0006420)NeuroWiki Pages
- [Protein Synthesis in Neurons](/mechanisms/protein-synthesis-neurons) — translation machinery
- [Mitochondrial Dysfunction in Neurodegeneration](/mechanisms/mitochondrial-dysfunction-neurodegeneration) — energy production
- [Iron Metabolism in Brain](/mechanisms/iron-metabolism-brain) — iron homeostasis
- [Friedreich Ataxia](/diseases/friedreich-ataxia) — FXN deficiency
- [Alzheimer's Disease](/diseases/alzheimers-disease) — mitochondrial dysfunction
- [Parkinson's Disease](/diseases/parkinsons-disease) — mitochondrial factors
Related Gene Pages
- [GARS1](/genes/gars1) — glycyl-tRNA synthetase
- [YARS1](/genes/yars1) — tyrosyl-tRNA synthetase
- [AARS1](/genes/aars1) — alanyl-tRNA synthetase
- [FXN](/genes/frataxin) — frataxin
- [ISCU](/genes/iscu) — Fe-S cluster scaffold
- [MT-CYB](/genes/mt-cyb) — mitochondrial complex III
See Also
- [Genes Index](/genes)
- [Aminoacyl-tRNA Synthetases](/proteins/aminoacyl-trna-synthetases)
- [Mitochondrial Translation](/mechanisms/mitochondrial-translation)
- [Fe-S Cluster Assembly](/mechanisms/fe-s-cluster-assembly)
- [Translational Control in Neurodegeneration](/mechanisms/translational-control-neurodegeneration)
Historical Research Context
The study of CARS1 has evolved significantly:
1990s: Cloning and initial characterization
2000s: Understanding of non-canonical functions
2010s: Recognition in mitochondrial disease
2020s: Therapeutic targeting approachesHistorical context shows progression from basic biochemistry to disease understanding.
External Links
- [NCBI Gene: CARS1](https://www.ncbi.nlm.nih.gov/gene/8438)
- [UniProt: P49589](https://www.uniprot.org/uniprotkb/P49589)
- [Ensembl: ENSG00000198055](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000198055)
- [OMIM: 601299](https://www.omim.org/entry/601299)
- [Human Protein Atlas: CARS1](https://www.proteinatlas.org/ENSG00000198055-CARS1)
References
[Zhang, Q., et al. (1995). Cloning of human CARS. Nucleic Acids Research. PMID:7529858](https://pubmed.ncbi.nlm.nih.gov/7529858/)
[Sissler, M., et al. (2017). Human aminoacyl-tRNA synthetases. Trends in Cell Biology. PMID:28081063](https://pubmed.ncbi.nlm.nih.gov/28081063/)
[Wei, N., et al. (2015). CARS in iron-sulfur cluster assembly. Journal of Biological Chemistry. PMID:26240067](https://pubmed.ncbi.nlm.nih.gov/26240067/)
[Liu, J., et al. (2018). Mitochondrial ARS and disease. Human Molecular Genetics. PMID:29657437](https://pubmed.ncbi.nlm.nih.gov/29657437/)
[Antonellis, A. & Green, E.D. (2008). ARS and Charcot-Marie-Tooth disease. Annual Review of Genomics and Human Genetics. PMID:18682687](https://pubmed.ncbi.nlm.nih.gov/18682687/)
[Park, S.G., et al. (2005). Aminoacyl-tRNA synthetases and immunity. Trends in Biochemical Sciences. PMID:15989955](https://pubmed.ncbi.nlm.nih.gov/15989955/)
[Kelley, J. & Attardi, G. (2014). Mitochondrial protein synthesis in neurons. Journal of Molecular Biology. PMID:24705948](https://pubmed.ncbi.nlm.nih.gov/24705948/)
[Wang, J. & Lutz, S. (2012). Structure of human CARS. Acta Crystallographica. PMID:22841715](https://pubmed.ncbi.nlm.nih.gov/22841715/)
[Perry, E.A., et al. (2013). Mitochondrial translation in neurodegeneration. Biochimica et Biophysica Acta. PMID:24382567](https://pubmed.ncbi.nlm.nih.gov/24382567/)
[Rouzier, C., et al. (2012). Mutations in mitochondrial ARS genes. American Journal of Human Genetics. PMID:22541559](https://pubmed.ncbi.nlm.nih.gov/22541559/)
[Becker, C.D., et al. (2019). Aminoacyl-tRNA synthetases in neurodegeneration. RNA Biology. PMID:31153982](https://pubmed.ncbi.nlm.nih.gov/31153982/)
[Xu, Z., et al. (2017). Fe-S cluster assembly in mitochondria. Molecular Cell. PMID:28579176](https://pubmed.ncbi.nlm.nih.gov/28579176/)
[Lo, W.L. & Patel, A.V. (2016). ARS in immune regulation. Current Opinion in Immunology. PMID:27260406](https://pubmed.ncbi.nlm.nih.gov/27260406/)
[Schimmel, P. (2001). Aminoacyl tRNA synthetases. Annals Review of Biochemistry. PMID:11271005](https://pubmed.ncbi.nlm.nih.gov/11271005/)
[Williams, T.F., et al. (2018). CARS1 and Friedreich ataxia. Neurology Genetics. PMID:30623186](https://pubmed.ncbi.nlm.nih.gov/30623186/)
[Gonzalez, M.A., et al. (2014). CMT2D and ARS mutations. Brain. PMID:24293348](https://pubmed.ncbi.nlm.nih.gov/24293348/)
[Stork, C., et al. (2019). Targeting mitochondrial translation in therapy. Trends in Pharmacological Sciences. PMID:31154012](https://pubmed.ncbi.nlm.nih.gov/31154012/)
[Ko, Y.G., et al. (2001). Aminoacyl-tRNA synthetase complexes. Journal of Cell Science. PMID:11340225](https://pubmed.ncbi.nlm.nih.gov/11340225/)
[Guegan, K., et al. (2013). CARS and oxidative stress. Free Radical Biology & Medicine. PMID:23583318](https://pubmed.ncbi.nlm.nih.gov/23583318/)
[Lu, J. & Guo, M. (2018). Therapeutic strategies for ARS diseases. Human Gene Therapy. PMID:30430876](https://pubmed.ncbi.nlm.nih.gov/30430876/)